Date & Time

Tuesday, November 3, 2026, 8:30 AM - 9:10 AM

Name

D. How Blood Tests Are Transforming Alzheimer's Diagnosis, and What It Means for Coverage

Session Type

Featured Session

Speakers

• Ben Tiede, Executive Director, Global CEO Initiative on Alzheimer's Disease
• Geoffrey Crawford, Staff Vice President, Office of Medical Policy and Technology Assessment, Elevance Health
• Jared Brosch, Associate Professor of Neurology, Indiana University